There is increased incidence of cancer worldwide but much of the burden of morbidity and mortality will occur in the developing world because of cancer associated infectious diseases of which HIV infection carries a large proportion. Site-based studies show that proportion of late stage cancer presentation range between 60% - 92% in the last 10 years. There is paucity of information on reasons for the late presentation. This study is aimed to find out the factors associated with delay in presentation of symptomatic cancers among HIV infected persons in Plateau State, Nigeria. A mixed method study consists of quantitative and qualitative component. Participants were sampled from HIV infected persons diagnosed with cancer and referred to the Oncology unit. Variables on Patient and health service factors associated with late presentation of cancers were collected. Quantitative data was analyzed using Epi info version 3.5.3 and Microsoft Excel while thematic analysis was done for qualitative data. There were 503 respondents and the mean age was 48.7 ± 13.5 years. Male sex OR 2.5, (P = 0.002); Farming occupation OR 1.7, (P = 0.0005) and Primary education OR 2.0, (P = 0.0005) were associated with delay. Majority of respondents 349(69%) presented more than six months after onset of symptom. Common symptoms were pain 462(45.70%), swelling 237(23.44%) and skin discoloration 210(20.77). Their Initial reaction was mainly the use of alternative remedies 234(46.5) CI 42.1 - 51.0. Up to 274(54.47%) of participants obtained diagnosis 3 months after presenting to a health facility. Laboratory related issues 199(39.56%) and long booking time 163(32.40%) were the most common reasons for delay. Delay was found to be both patient and services related. The study also suggests that cancer symptom awareness is poor among the participants. There is no tangible cancer prevention program in the HIV/AIDs treatment program. A more in-depth knowledge of cancer is required for both the sufferer and the care giver.
References
[1]
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., et al. (2012) Global Burden of Cancers Attributable to Infections in 2008: A Review and Synthetic Analysis. The Lancet Oncology, 13, 607-615.
https://doi.org/10.1016/S1470-2045(12)70137-7
[2]
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F. and Franceschi, S. (2016) Global Burden of Cancers Attributable to Infections in 2012: A Synthetic Analysis. The Lancet Global health, 4, e609-e616.
https://doi.org/10.1016/s2214-109x(16)30143-7
[3]
Deeken, J.F., Tjen-A-Looi, A., Rudek, M.A., Okuliar, C., Young, M., Little, R.F. and Dezube, B.J. (2012) The Rising Challenge of Non–AIDS-Defining Cancers in HIV-Infected Patients. Clinical Infectious Diseases, 55, 1228-1235.
https://doi.org/10.1093/cid/cis613
[4]
Hatakeyama, M. and Higashi, H. (2005) Helicobacter Pylori CagA: A New Paradigm for Bacterial Carcinogenesis. Cancer Science, 96, 835-843.
https://doi.org/10.1111/j.1349-7006.2005.00130.x
[5]
Bonnet, F., Lewden, C., May, T., Heripret, L., Jougla, E., Bevilacqua, S., et al. (2004) Malignancy-Related Causes of Death in Human Immunodeficiency Virus–Infected Patients in the Era of Highly Active Antiretroviral Therapy. Cancer, 101, 317-324.
https://doi.org/10.1002/cncr.20354
[6]
Ziegler, J.L. and Buonaguro, F.M. (2009) Infectious Agents and Human Malignancies. Frontiers in Bioscience, 14, 3455-3464. https://doi.org/10.2741/3464
[7]
Kanavos, P. (2006) The Rising Burden of Cancer in the Developing World. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 17 (Suppl 8), viii15-viii23. https://doi.org/10.1093/annonc/mdl983
[8]
Federal Republic of Nigeria Global Aids Response Country Progress Report Nigeria GARPR 2015 ABUJA, NIGERIA National Agency for the Control of AIDS (NACA).
[9]
Gowmwalk, N.E. (2012) Seroprevalence of Human Immunodeficiency Virus (HIV) in Plateau State, Nigeria. Journal of Infection in Developing Countries, 6, 860-869.
[10]
Bashorun, A., Nguku, P., Kawu, I., Ngige, E., Ogundiran, A., Sabitu, K., et al. (2014) A Description of HIV Prevalence Trends in Nigeria from 2001 to 2010: What Is the Progress, Where Is the Problem? The Pan African Medical Journal, 18(Suppl 1), 3.
https://doi.org/10.11604/pamj.supp.2014.18.1.4608
[11]
Goedert, J.J., Hosgood, H.D., Biggar, R.J., Strickler, H.D. and Rabkin, C.S. (2016) Screening for Cancer in Persons Living with HIV Infection. Trends in Cancer, 2, 416-428. https://doi.org/10.1016/j.trecan.2016.06.007
[12]
Natl, J. (2000) Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected Adults. Journal of the National Cancer Institute, 92, 1823-1830. https://doi.org/10.1093/jnci/92.22.1823
[13]
Grulich, A.E., Li, Y., McDonald, A., Correll, P.K., Law, M.G. and Kaldor, J.M. (2012) Rates of Non-AIDS-Defining Cancers in People with HIV Infection before and after AIDS Diagnosis. National Centre in HIV Epidemiology and Clinical Research, Darlinghurst.
[14]
Barnes, T.A., Amir, E., Templeton, A.J., Gomez-Garcia, S., Navarro, B., Seruga, B., et al. (2017) Efficacy, Safety, Tolerability and Price of Newly Approved Drugs in Solid Tumors. Cancer Treatment Reviews, 56, 1-7.
https://doi.org/10.1016/j.ctrv.2017.03.011
[15]
Fatimah, A. (2009) Epidemiology and Incidence of Common Cancers in Nigeria. Cancer Registry and Epidemiology Workshop, Lagos.
[16]
Merriam, S. and Muhamad, M. (2013) Roles Traditional Healers Play in Cancer Treatment in Malaysia: Implications for Health Promotion and Education. Asian Pacific Journal of Cancer Prevention, 14, 3593-3601.
https://doi.org/10.7314/APJCP.2013.14.6.3593
[17]
Whitaker, K.L., Scott, S.E., Winstanley, K., Macleod, U. and Wardle, J. (2014) Attributions of Cancer “Alarm” Symptoms in a Community Sample. PloS One, 9, e114028.
[18]
Cromme, S.K., Whitaker, K.L., Winstanley, K., Renzi, C., Smith, C.F. and Wardle, J. (2016) Worrying about Wasting GP Time as a Barrier to Help-Seeking: A Community-Based, Qualitative Study. The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 66, e474-e482.
https://doi.org/10.3399/bjgp16x685621
[19]
Whitaker, K.L., Smith, C.F., Winstanley, K. and Wardle, J. (2016) What Prompts Help-Seeking for Cancer “Alarm” Symptoms? A Primary Care Based Survey. British Journal of Cancer, 114, 334-339. https://doi.org/10.1038/bjc.2015.445
[20]
Ibrahim, N.A. and Oludara, M.A. (2012) Socio-Demographic Factors and Reasons Associated with Delay in Breast Cancer Presentation: A Study in Nigerian Women. Breast, 21, 416-418. https://doi.org/10.1016/j.breast.2012.02.006
[21]
Pace, L.E., Mpunga, T., Hategekimana, V., Dusengimana, J.M., Habineza, H., Bigirimana, J.B., et al. (2015) Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda. The Oncologist, 20, 780-788.
https://doi.org/10.1634/theoncologist.2014-0493
[22]
Macleod, U., Mitchell, E.D., Burgess, C., Macdonald, S. and Ramirez, A.J. (2009) Risk Factors for Delayed Presentation and Referral of Symptomatic Cancer: Evidence for Common Cancers. British Journal of Cancer, 101, S92-S101.
https://doi.org/10.1038/sj.bjc.6605398
